Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Summary
The aim of this trial is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS9531 injection compared with placebo in adolescents with obesity
Official title: A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of HRS9531 Injection in Chinese Adolescents With Obesity
Key Details
Gender
All
Age Range
12 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2026-05
Completion Date
2027-02
Last Updated
2026-04-30
Healthy Volunteers
No
Conditions
Interventions
HRS9531 injection;Placebo
Drug: HRS9531 injection; low dose Drug: Placebo
HRS9531 injection;Placebo
Drug: HRS9531 injection; medium dose Drug: Placebo
HRS9531 injection;Placebo
Drug: HRS9531 injection; high dose Drug: Placebo
Locations (1)
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China